Innate Pharma has signed a co-development and commercialization agreement with AstraZeneca Read the full story

Celgene has entered into a strategic collaboration with MedImmune to develop and commercialize an anti-PD-L1 inhibitor, MEDI4736, for hematologic malignancies Read the full story

PatientsLikeMe and AstraZeneca have signed a five-year agreement to provide access to PatientsLikeMe’s global network in support of AstraZeneca’s patient-driven research initiatives Read the full story

AstraZeneca announced a co-commercialisation agreement with Daiichi Sankyo for MOVANTIK (naloxegol) Read the full story

PhaseBio Pharmaceuticals has closed a $40 million Series C financing round led by AstraZeneca. Read the full story

AstraZeneca has decided to carve out its early-stage antibiotic research by creating a stand-alone subsidiary company Read the full story

Orca Pharmaceuticals and AstraZeneca announced a three year collaboration to develop inhibitors of retinoic acid–related orphan nuclear receptor gamma Read the full story

AstraZeneca and Actavis have entered into a definitive asset purchase agreement under which AstraZeneca will acquire the rights to Actavis’ branded respiratory business in the US and Canada for an initial consideration of Read the full story

AstraZeneca announces collaborations to use CRISPR technology for genome editing across its drug discovery platform Read the full story

Molplex Pharmaceuticals has announced a pioneering new research collaboration agreement with AstraZeneca Read the full story